4.3(top 10%)
impact factor
1.5K(top 10%)
papers
46.3K(top 10%)
citations
98(top 5%)
h-index
4.5(top 10%)
impact factor
1.7K
all documents
49.4K
doc citations
137(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotectionHeart Failure Reviews2007436
2Diabetic cardiomyopathy: pathophysiology and clinical featuresHeart Failure Reviews2013368
3Return to the fetal gene program protects the stressed heart: a strong hypothesisHeart Failure Reviews2007364
4Age-associated cardiovascular changes in health: impact on cardiovascular disease in older personsHeart Failure Reviews2002354
5The mechanisms of air pollution and particulate matter in cardiovascular diseasesHeart Failure Reviews2017298
6Fibrosis and heart failureHeart Failure Reviews2014291
7Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatmentHeart Failure Reviews2012287
8Signaling pathways in ischemic preconditioningHeart Failure Reviews2007286
9Systemic inflammation in heart failure – The whys and whereforesHeart Failure Reviews2006252
10The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based reviewHeart Failure Reviews2008237
11Strain imaging using cardiac magnetic resonanceHeart Failure Reviews2017236
12Energy metabolism in the normal and failing heart: potential for therapeutic interventionsHeart Failure Reviews2002233
13Clinical Characteristics, Demographics and Prognosis of Transient Left Ventricular Apical Ballooning SyndromeHeart Failure Reviews2005227
14The fibrosis-cell death axis in heart failureHeart Failure Reviews2016214
15Regulation of Matrix Metalloproteinases by Cytokines and Reactive Oxygen/Nitrogen Species in the MyocardiumHeart Failure Reviews2004213
16TNFα in myocardial ischemia/reperfusion, remodeling and heart failureHeart Failure Reviews2011207
17Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalitiesHeart Failure Reviews2011201
18Age-associated changes in cardiovascular structure and function: a fertile milieu for future diseaseHeart Failure Reviews2012199
19Mitochondrial dysfunction in heart failureHeart Failure Reviews2013196
20Chronic kidney disease and cardiovascular complicationsHeart Failure Reviews2015194
21Mineralocorticoid Receptors: Distribution and ActivationHeart Failure Reviews2005189
22Symptom burden in heart failure: assessment, impact on outcomes, and managementHeart Failure Reviews2017186
23Role of cytokines and inflammation in heart function during health and diseaseHeart Failure Reviews2018186
24Proinflammatory cytokines in heart failure: double-edged swordsHeart Failure Reviews2010181
25Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugsHeart Failure Reviews2015178
26Biomarkers of inflammation in heart failureHeart Failure Reviews2010169
27Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysisHeart Failure Reviews2016169
28Cardiac tissue engineering for replacement therapyHeart Failure Reviews2003168
29β-Adrenergic stimulation and myocardial function in the failing heartHeart Failure Reviews2009168
30Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndromeHeart Failure Reviews2012167
31Sarcomeric Proteins and Familial Hypertrophic Cardiomyopathy: Linking Mutations in Structural Proteins to Complex Cardiovascular PhenotypesHeart Failure Reviews2005165
32Matrix Metalloproteinase Inhibitor Development and the Remodeling of Drug DiscoveryHeart Failure Reviews2004164
33BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic reviewHeart Failure Reviews2014164
34Pharmacokinetics and Pharmacodynamics of Mineralocorticoid Blocking Agents and their Effects on Potassium HomeostasisHeart Failure Reviews2005160
35Frailty and multiple comorbidities in the elderly patient with heart failure: implications for managementHeart Failure Reviews2012157
36Age-related changes in venticular-arterial coupling: pathophysiologic implicationsHeart Failure Reviews2002156
37Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetesHeart Failure Reviews2016156
38Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery diseaseHeart Failure Reviews2017156
39Metabolic abnormalities in the diabetic heartHeart Failure Reviews2002155
40Natriuretic peptides and therapeutic applicationsHeart Failure Reviews2007155
41Advanced glycation end products: role in pathology of diabetic cardiomyopathyHeart Failure Reviews2014154
42Heart failure and COVID-19Heart Failure Reviews2021152
43Energy metabolism in the hypertrophied heartHeart Failure Reviews2002151
44Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directionsHeart Failure Reviews2011151
45Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growthHeart Failure Reviews2002150
46Cardiac hypertrophy and thyroid hormone signalingHeart Failure Reviews2010149
47Mitochondria and cardioprotectionHeart Failure Reviews2007148
48Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspectsHeart Failure Reviews2007147
49Cardiac amyloidosis: the great pretenderHeart Failure Reviews2015147
50Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measuresHeart Failure Reviews2014141